{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:06:16Z","timestamp":1774526776436,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["483714\/2013-5"],"award-info":[{"award-number":["483714\/2013-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.htct.2020.03.006","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T16:36:30Z","timestamp":1591288590000},"page":"243-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association of HMIP1 C-893A polymorphism and disease severity in patients with sickle cell anemia"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3302-4311","authenticated-orcid":false,"given":"Diego A.","family":"Pereira-Martins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5292-5417","authenticated-orcid":false,"given":"Igor F.","family":"Domingos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6478-8173","authenticated-orcid":false,"given":"Edis","family":"Belini-Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan L.","family":"Coelho-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Weinh\u00e4user","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aderson S.","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarisse L.","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia R.","family":"Bonini-Domingos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos A.","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio R.","family":"Lucena-Araujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.htct.2020.03.006_bib0005","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"Eng J Med [Internet]"},{"issue":"April (7)","key":"10.1016\/j.htct.2020.03.006_bib0010","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/1535370216636726","article-title":"Minireview: Genetic basis of heterogeneity and severity in sickle cell disease","volume":"241","author":"Habara","year":"2016","journal-title":"Exp Biol Med (Maywood) [Internet]"},{"issue":"1","key":"10.1016\/j.htct.2020.03.006_bib0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.blre.2006.07.001","article-title":"Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes","volume":"21","author":"Kato","year":"2007","journal-title":"Blood Rev"},{"issue":"33","key":"10.1016\/j.htct.2020.03.006_bib0020","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1073\/pnas.0804799105","article-title":"DNA polymorphisms at the BCL11A, HBS1L-MYB, and -globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease","volume":"105","author":"Lettre","year":"2008","journal-title":"Proc Natl Acad Sci [Internet]"},{"issue":"August (9)","key":"10.1016\/j.htct.2020.03.006_bib0025","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1182\/blood-2012-06-432849","article-title":"Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans","volume":"120","author":"Bae","year":"2012","journal-title":"Blood [Internet]"},{"issue":"August (8)","key":"10.1016\/j.htct.2020.03.006_bib0030","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ajh.23232","article-title":"Genetic modifiers of sickle cell disease","volume":"87","author":"Steinberg","year":"2012","journal-title":"Am J Hematol [Internet]"},{"issue":"1","key":"10.1016\/j.htct.2020.03.006_bib0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ajh.21572","article-title":"Genetic modifiers of the severity of sickle cell anemia identified through a genome-wide association study","volume":"85","author":"Sebastiani","year":"2010","journal-title":"Am J Hematol"},{"issue":"June (23)","key":"10.1016\/j.htct.2020.03.006_bib0040","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med [Internet]"},{"issue":"July (1)","key":"10.1016\/j.htct.2020.03.006_bib0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood-2011-03-325258","article-title":"Fetal hemoglobin in sickle cell anemia","volume":"118","author":"Akinsheye","year":"2011","journal-title":"Blood [Internet]"},{"issue":"4","key":"10.1016\/j.htct.2020.03.006_bib0050","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2141.2005.05411.x","article-title":"Predicting clinical severity in sickle cell anaemia","volume":"129","author":"Steinberg","year":"2005","journal-title":"Br J Haematol"},{"issue":"October 2017","key":"10.1016\/j.htct.2020.03.006_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcmd.2017.11.003","article-title":"A long noncoding RNA from the HBS1L-MYB intergenic region on chr6q23 regulates human fetal hemoglobin expression","volume":"69","author":"Morrison","year":"2018","journal-title":"Blood Cells, Mol Dis"},{"issue":"3","key":"10.1016\/j.htct.2020.03.006_bib0060","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/bjh.13961","article-title":"Reduced rate of sickle-related complications in Brazilian patients carrying HbF-promoting alleles at the BCL11A and HMIP-2 loci","volume":"173","author":"Leonardo","year":"2016","journal-title":"Br J Haematol"},{"issue":"March (3)","key":"10.1016\/j.htct.2020.03.006_bib0065","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/ajcp\/61.3.375","article-title":"On the levels of hemoglobins F and A2 in sickle-cell anemia and some related disorders","volume":"61","author":"Wrightstone","year":"1974","journal-title":"Am J Clin Pathol [Internet]"},{"issue":"1","key":"10.1016\/j.htct.2020.03.006_bib0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF01928784","article-title":"Hb F in sickle cell anemia","volume":"49","author":"Adekile","year":"1993","journal-title":"Experientia"},{"issue":"August (2)","key":"10.1016\/j.htct.2020.03.006_bib0075","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1172\/JCI111464","article-title":"Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia","volume":"74","author":"Platt","year":"1984","journal-title":"J Clin Invest [Internet]"},{"issue":"May (20)","key":"10.1016\/j.htct.2020.03.006_bib0080","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med [Internet]"},{"key":"10.1016\/j.htct.2020.03.006_bib0085","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMct0708272","article-title":"Hydroxyurea for the Treatment of Sickle Cell Anemia","author":"Platt","year":"2008","journal-title":"N Engl J Med [Internet]"},{"issue":"September (5)","key":"10.1016\/j.htct.2020.03.006_bib0090","first-page":"1550","article-title":"Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I\/II trial. Pediatric Hydroxyurea Group","volume":"94","author":"Kinney","year":"1999","journal-title":"Blood [Internet]"},{"issue":"March (6)","key":"10.1016\/j.htct.2020.03.006_bib0095","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1182\/blood-2003-07-2475","article-title":"Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease","volume":"103","author":"Zimmerman","year":"2004","journal-title":"Blood [Internet]"},{"key":"10.1016\/j.htct.2020.03.006_bib0100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1182\/asheducation-2009.1.62","article-title":"Advances in the use of hydroxyurea","author":"Ware","year":"2009","journal-title":"Hematol Am Soc Hematol Educ Progr [Internet]"},{"issue":"January (1)","key":"10.1016\/j.htct.2020.03.006_bib0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1182\/blood.V99.1.10","article-title":"Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy","volume":"99","author":"Ware","year":"2002","journal-title":"Blood [Internet]"},{"issue":"February (1)","key":"10.1016\/j.htct.2020.03.006_bib0110","first-page":"35","article-title":"Dominant influence of gamma-globin promoter polymorphisms on fetal haemoglobin expression in sickle cell disease","volume":"50","author":"Ofori-Acquah","year":"2004","journal-title":"Cell Mol Biol (Noisy-le-grand) [Internet]"},{"issue":"February (1)","key":"10.1016\/j.htct.2020.03.006_bib0115","first-page":"23","article-title":"Polymorphisms near a chromosome 6q QTL area are associated with modulation of fetal hemoglobin levels in sickle cell anemia","volume":"50","author":"Wyszynski","year":"2004","journal-title":"Cell Mol Biol (Noisy-le-grand) [Internet]"},{"issue":"June (12)","key":"10.1016\/j.htct.2020.03.006_bib0120","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1182\/blood-2005-07-2968","article-title":"Coordination of erythropoiesis by the transcription factor c-Myb","volume":"107","author":"Vegiopoulos","year":"2006","journal-title":"Blood [Internet]"},{"issue":"6","key":"10.1016\/j.htct.2020.03.006_bib0125","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1182\/blood-2009-03-210146","article-title":"The HBS1L-MYB intergenic interval associated with elevated HbF levels shows characteristics of a distal regulatory region in erythroid cells","volume":"114","author":"Wahlberg","year":"2009","journal-title":"Blood"},{"issue":"January (4)","key":"10.1016\/j.htct.2020.03.006_bib0130","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1073\/pnas.1018384108","article-title":"MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13","volume":"108","author":"Sankaran","year":"2011","journal-title":"Proc Natl Acad Sci U S A [Internet]"},{"issue":"November (11)","key":"10.1016\/j.htct.2020.03.006_bib0135","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jmg.2008.060335","article-title":"The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia","volume":"45","author":"So","year":"2008","journal-title":"J Med Genet [Internet]"},{"issue":"4","key":"10.1016\/j.htct.2020.03.006_bib0140","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1172\/JCI71520","article-title":"HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers","volume":"124","author":"Stadhouders","year":"2014","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.htct.2020.03.006_bib0145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00439-009-0770-2","article-title":"A genome-wide association identified the common genetic variants influence disease severity in \u03b2-thalassemia\/hemoglobin","volume":"127","author":"Nuinoon","year":"2010","journal-title":"Hum Genet"},{"issue":"5","key":"10.1016\/j.htct.2020.03.006_bib0150","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2174\/1566524018666181004121604","article-title":"Genetic modifiers of fetal haemoglobin (HbF) and phenotypic severity in \u03b2-thalassemia patients","volume":"18","author":"Razak","year":"2018","journal-title":"Curr Mol Med [Internet]"},{"issue":"10","key":"10.1016\/j.htct.2020.03.006_bib0155","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1182\/blood-2007-05-093419","article-title":"The HBS1L-MYB intergenic region on chromosome 6q23.3 influences erythrocyte, platelet, and monocyte counts in humans","volume":"110","author":"Menzel","year":"2007","journal-title":"Blood"},{"issue":"November (11)","key":"10.1016\/j.htct.2020.03.006_bib0160","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/ng.467","article-title":"A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium","volume":"41","author":"Soranzo","year":"2009","journal-title":"Nat Genet [Internet]"},{"issue":"January (1)","key":"10.1016\/j.htct.2020.03.006_bib0165","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.4238\/2015.March.31.18","article-title":"A rapid screening of ancestry for genetic association studies in an admixed population from Pernambuco, Brazil","volume":"14","author":"Coelho","year":"2015","journal-title":"Genet Mol Res [Internet]"},{"issue":"January (1)","key":"10.1016\/j.htct.2020.03.006_bib0170","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3109\/03014460.2012.742138","article-title":"Analysis of genetic ancestry in the admixed Brazilian population from Rio de Janeiro using 46 autosomal ancestry-informative indel markers","volume":"40","author":"Manta","year":"2013","journal-title":"Ann Hum Biol [Internet]"},{"issue":"6","key":"10.1016\/j.htct.2020.03.006_bib0175","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/bjh.15462","article-title":"Clinical and genetic ancestry profile of a large multi-centre sickle cell disease cohort in Brazil","volume":"182","author":"Carneiro-Proietti","year":"2018","journal-title":"Br J Haematol"},{"issue":"July (27)","key":"10.1016\/j.htct.2020.03.006_bib0180","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1073\/pnas.0611393104","article-title":"Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults","volume":"104","author":"Thein","year":"2007","journal-title":"Proc Natl Acad Sci U S A [Internet]"},{"issue":"3","key":"10.1016\/j.htct.2020.03.006_bib0185","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1182\/bloodadvances.2017009811","article-title":"G(HbF): a genetic model of fetal hemoglobin in sickle cell disease","volume":"2","author":"Gardner","year":"2018","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.htct.2020.03.006_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0197927","article-title":"A survey of genetic fetal-haemoglobin modifiers in Nigerian patients with sickle cell anaemia","volume":"13","author":"Adeyemo","year":"2018","journal-title":"PLoS One"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137920300596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137920300596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:33:38Z","timestamp":1762868018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137920300596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2531137920300596"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2020.03.006","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of HMIP1 C-893A polymorphism and disease severity in patients with sickle cell anemia","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2020.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}